Silver Complex Coated Orthopedic Alloy Surface
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Periprosthetic infections in orthopedic and dental implants due to bacterial colonization and biofilm formation on implant surfaces are a significant concern, with existing antimicrobial coatings facing challenges related to biocompatibility, efficacy, and long-term sterility assurance, particularly with titanium oxide substrates that can cause inflammation and infection.
Innovation Solution
A Chromium-Cobalt-Molybdenum alloy coated with a silver complex derivative, where the alloy is prepared through gritblasting, alkaline washing, acidic passivation, linker deposition, silver compound coating, and multistep biological washing, forming a durable and biocompatible antimicrobial surface that inhibits bacterial growth and releases bactericidal silver ions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If titanium oxide substrate is used for implant coating, then antimicrobial activity can be achieved, but bone integration is compromised and inflammation occurs due to particle removal during wear
Solution Approach 1:
The patent uses a composite coating system consisting of titanium oxide substrate combined with silver complex derivative coating. This composite structure allows the titanium oxide to provide antimicrobial activity while the silver complex provides biocompatibility and prevents inflammation, resolving the contradiction between antimicrobial efficacy and biological safety
Solution Approach 2:
The patent modifies the chemical composition and structure of the coating by introducing silver complex derivatives with specific ligands and linkers. This parameter change transforms the coating from purely titanium oxide (which causes inflammation) to a composite material that maintains antimicrobial activity while eliminating harmful effects through controlled chemical composition
2Duration of action of moving object
If silver ions are released for long-term antimicrobial activity, then bacterial adhesion is prevented, but cytotoxicity may occur
Solution Approach 1:
The patent carefully controls the silver ion release rate by selecting specific ligands and linkers in the silver complex derivative. This parameter optimization allows sustained antimicrobial activity over at least 24 days while maintaining silver ion concentration below cytotoxic thresholds, resolving the contradiction between duration of action and safety
Solution Approach 2:
The ligand and linker molecules act as intermediaries between the silver ions and the biological environment. They control the release kinetics and bioavailability of silver ions, enabling long-term antimicrobial protection while preventing acute cytotoxic effects through regulated ion delivery
3Object-affected harmful factors
If chromium-cobalt-molybdenum alloy is used as substrate, then biocompatibility and bone integration are improved, but manufacturing complexity increases compared to titanium
Solution Approach 1:
The patent uses CrCoMo alloy as the substrate material, which is known for superior biocompatibility and bone integration properties compared to titanium. Although CrCoMo manufacturing is more complex, the patent simplifies the overall process by using standard medical-grade alloy fabrication techniques and a relatively simple surface coating procedure
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The alloy surface effectively prevents bacterial adhesion and biofilm formation, providing long-term antimicrobial activity, high biocompatibility, and reduced risk of infection, with silver ion release lasting at least 24 days and maintaining non-toxicity and bio-integration.
Implementation Method 1
The surface is coated with a silver (Ag+) complex derivative... —Ligand— is a divalent group... —linker— is a divalent group... wherein the ligand binds the Ag+ ions by the at least one heteroatom of the terminal aromatic rings
Implementation Method 2
silver ion release lasting at least 24 days... releases bactericidal silver ions
Implementation Method 3
prevents bacterial adhesion: the surface is 'lubricious' (for example hydrogel coatings or cross linked silicon containing coating layer)
Implementation Method 4
silver compound dip-coating or spraying, and drying... silver compound coating
Implementation Method 5
linker deposition with isonicotinic acid... linker binds the Ag+ atom
Data Source
AI summary
The present invention relates to orthopedic implants, in particular to hip and knee prostheses, substantially involving metallic substrates with an antibacterial surface treatment consisting of silver immobilized in an organic linker and ligand via a multistep solution dipping and drying process. This treatment while being biocompatible is designed to inhibit bacterial growth and therefore combat periprosthetic infection which is one of the main causes of revision in hip and knee arthroplasty.